Skip to main content

Table 5 Locoregional response and relapse characteristics for patients with and without glutamine supplementation

From: Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer

Characteristic

All

Glutamine (+)

Glutamine (−)

P-value

 

(N=104)

(N=56)

(N=48)

 

Locoregional response (N; %)

    

Complete

15 (14.4)

8 (14.3)

7 (14.5)

0.79

Partial

34 (32.7)

18 (32.1)

16 (33.4)

0.62

Stable

28 (26.9)

16 (28.6)

12 (25.0)

0.31

Progression

27 (26.0)

14 (25.0)

13 (27.1)

0.43

Relapse pattern (N; %)

    

None

19 (18.3)

10 (17.9)

9 (18.8)

0.42

Locoregional

20 (19.2)

10 (17.9)

10 (20.8)

0.59

Distant

46 (44.2)

25 (44.6)

21 (43.7)

0.30

Locoregional + distant

19 (18.3)

11 (19.6)

8 (16.7)

0.24